Tim Delany

Delighted with this one - a few years in the making! 😄 Great to be partnering with one of the world’s largest health studies to advance precision health through metabolomics. Looking forward to seeing the insights generated from integrating our data with ethnically diverse multiomic data

10.09.2025 13:57 — 👍 0    🔁 0    💬 0    📌 0

https://www.metabolon.com/resources/videos/multiomic-integration-metabolome-biological-aging-precision-medicine-in-autism-asthma/

Metabolon extends heartfelt congratulations to Dr. Jessica Lasky-Su on her well-deserved recognition as an Honorary Fellow of the Metabolomics Society. Dr. Lasky-Su has been a pioneering force in the field, advancing our understanding of how metabolic perturbations influence human health outcomes.

23.06.2025 18:48 — 👍 4    🔁 1    💬 0    📌 0

Nice use of poly-metabolite scores for looking at UPFs using @metabolon.bsky.social data.

20.05.2025 22:06 — 👍 3    🔁 0    💬 0    📌 0

Looking forward to seeing the various research outputs from the new microbiome solution. This product has been in the works for quite some time!

29.04.2025 16:16 — 👍 0    🔁 0    💬 0    📌 0

Nice paper from Fredrik Backhed's lab looking at the #microbiome in Type 2 Diabetes.

09.04.2025 14:59 — 👍 2    🔁 0    💬 0    📌 0

Gut microbiota and metabolites are linked to disease progression in multiple sclerosis Understanding pathobiology at the shift from relapsing to progressive multiple sclerosis (MS) is critically important. In this study, Schwerdtfeger et al. use a 2-year follow-up cohort to show that su...

🧠 🧬A new paper from @harvardmed.bsky.social using Metabolon's data links gut-derived metabolites, especially from the tryptophan pathway, to Multiple Sclerosis inflammation via AHR receptor signaling—unlocking potential new therapeutic targets.

mtbln.co/cg3ozu

#Metabolomics

04.04.2025 17:06 — 👍 2    🔁 2    💬 0    📌 0

Interesting paper looking at microbial metabolites' link with Multiple Scelerosis.

Delighted @metabolon.bsky.social could contribute.

03.04.2025 20:21 — 👍 0    🔁 0    💬 0    📌 0

Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints - Nature Communications Metabolites can be used to estimate disease risk. Here, the authors use Mendelian randomization to infer the potential causal effects of 1099 plasma metabolites on the risk of 2099 binary disease endp...

Interesting new paper from the METSIM & FinnGen, which "uncovered causal effects of plasma metabolites on a broad spectrum of human diseases"

www.nature.com/articles/s41...

02.04.2025 10:21 — 👍 1    🔁 0    💬 0    📌 0

Love this resource. There are a few Metabolon ones missing - I'll mail you later with them!

14.02.2025 14:06 — 👍 1    🔁 0    💬 1    📌 0

Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome Background/Objectives: Irritable bowel syndrome (IBS) is a complex disorder affecting 10% of the global population, but the underlying mechanisms remain poorly understood. By integrating multifluid me...

Interesting new publication out on novel biomarker signatures for IBS distinctly seen across sample types.

www.mdpi.com/2218-1989/15...

12.02.2025 15:36 — 👍 1    🔁 0    💬 0    📌 0

I'll be in London later this week for this event. Keen to catch-up with old friends and new faces.

#FOG2025

27.01.2025 17:37 — 👍 2    🔁 1    💬 0    📌 0

Have enjoyed reading other intros here, so figured I'd partake

Currently based out of Dublin, by day I've a keen interest in the potential of multiomics - working on partnerships and collaborations in @metabolon.bsky.social

Outside of work you'll find me somewhere outdoors, most likely the hills!

24.01.2025 16:00 — 👍 3    🔁 0    💬 0    📌 0